Figure 5 | Scientific Reports

Figure 5

From: Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients

Figure 5

Evolution of cell populations in patients with chronic (more than 6 months) HIV infection (n = 9) after after 6 and 12 months of antiretroviral therapy. (A) Myeloid dendritic cells (percentage of leukocytes). (B) Myeloid dendritic cells expressing interleukin 12 (percentage of total myeloid dendritic cells). (C) Plasmacytoid dendritic cells (percentage of leukocytes). (D) Plasmacytoid dendritic cells expressing interferon alpha (percentage of total plasmacytoid dendritic cells). (E) Th1 cells (percentage of CD4+ T cells with intracellular expression of interferon gamma). (F) Th2 cells (percentage of CD4+ T cells with intracellular expression of interleukin 4). (G) T regulatory cells (CD4+ CD25highFoxP3+) (percentage of total CD4+ T cells). (H) T regulatory cells with intracellular expression of transforming growth factor beta 1 (percentage of T regulatory cells). (I) T regulatory cells with intracellular expression of interleukin 10 (percentage of T regulatory cells). (J) Myeloid-derived suppressor cells (percentage of leukocytes). (K) Myeloid-derived suppressor cells with intracellular expression of interleukin 10 (percentage of granulocyte myeloid-derived suppressor cells).

Back to article page